We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPATH.L Regulatory News (PATH)

  • There is currently no data for PATH

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Share Transaction

24 Mar 2021 14:06

RNS Number : 3769T
Path Investments plc
24 March 2021
 

 

24 March 2021

Path Investments plc("Path" or the "Company")

Director/PDMR Share Transaction

 

 

Path Investments plc (TIDM: PATH) announces that it was notified on 24 March 2021 that John Allardyce a director/person discharging managerial responsibility in the Company has, in order to transfer his shareholding in the Company into his ISA and SIPP, sold 6,000,000 ordinary shares of 0.1 pence each in the Company ("Ordinary Shares") at a price of 0.2615 pence per Ordinary Share and then repurchased into his SIPP 2,400,000 Ordinary Shares at a price of 0.2770 pence per Ordinary Share and 3,600,000 Ordinary Shares into his ISA at a price of 0.2750 pence per Ordinary Share. The transactions took place on 24 March 2021 and further information is contained in the disclosure tables below.

 

The transactions were entered into in accordance with an exception from the lock up arrangements applicable to Existing Directors as described and defined in the Company's prospectus published on 12 March 2021.

 

Following the transactions, there has been no change in the number of the Company's shares in which John Allardyce has an interest.

 

For further information please contact:

Path Investments plc

C/O IFC

Christopher Theis

Jack Allardyce

IFC Advisory (Financial PR & IR)

020 3934 6630

Tim Metcalfe

Zach Cohen

Grant Thornton UK LLP (Financial Adviser)

Jamie Barklem

Samantha Harrison

Harrison Clarke

020 7383 5100

 

ETX Capital (Broker)

020 7392 1400

Elliot Hance

 

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

1.

Details of Director/PDMR

(a)

Name

John Allardyce

2.

Reason for notification

(b)

Position / status

Director

 

(c)

Initial notification / amendment

Initial notification

3.

Details of the Issuer

(a)

Name

Path Investments plc

(b)

LEI

21380058VQBP76M7TN11

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) have been conducted

(a)

Description of the financial instrument, type of instrument, Identification code

Ordinary shares of 0.1 pence each

ISIN GB00BYQD5059

PATH

(b)

Nature of the transaction

Sale of Ordinary Shares

(c)

Price(s) and volume

 Price

Volume

0.2615 pence

6,000,000

 

 

 

 

 

(d)

Aggregated information

Aggregated Volume

Price

 

 

6,000,000

£15,690.00

(e)

Date of the transactions

24 March 2021

 

(f)

Place of the transactions

London Stock Exchange

 

 

1.

Details of Director/PDMR

(a)

Name

John Allardyce

2.

Reason for notification

(b)

Position / status

Director

 

(c)

Initial notification / amendment

Initial notification

3.

Details of the Issuer

(a)

Name

Path Investments plc

(b)

LEI

21380058VQBP76M7TN11

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) have been conducted

(a)

Description of the financial instrument, type of instrument, Identification code

Ordinary shares of 0.1 pence each

ISIN GB00BYQD5059

PATH

(b)

Nature of the transaction

Purchase of Ordinary Shares

(c)

Price(s) and volume

 Price

Volume

0.2770 pence

2,400,000

0.2750 pence

3,600,000

 

 

 

(d)

Aggregated information

Aggregated Volume

Price

 

 

6,000,000

£16,548.00

(e)

Date of the transactions

24 March 2021

 

(f)

Place of the transactions

London Stock Exchange

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHUSRSRAOUOUAR
Date   Source Headline
7th Apr 20227:00 amRNSUpdate on Acquisition
5th Apr 20227:00 amRNSInvestor Presentation
1st Apr 20222:45 pmRNSResult of General Meeting
14th Mar 20221:09 pmRNSPublication of Prospectus, Notice of GM, Fundraise
1st Feb 20227:00 amRNSProposed Transaction Update
31st Dec 20217:00 amRNSProposed Transaction Update
18th Nov 20217:00 amRNSAppointment of Joint Broker
26th Oct 20217:00 amRNSProposed Transaction Update
13th Oct 20216:02 pmRNSCorrection: Holding(s) in Company
13th Oct 20214:52 pmRNSHolding(s) in Company
11th Oct 20217:00 amRNSBlock listing Interim Review
29th Sep 20217:00 amRNSInterim Results for the six months to 30 June 2021
28th Sep 20212:45 pmRNSResult of AGM
22nd Sep 20212:41 pmRNSFurther secured loan provided to DG Innovate
9th Sep 20216:01 pmRNSHolding(s) in Company
2nd Sep 20217:00 amRNSNotice of AGM
18th Aug 202111:54 amRNSCorrection: Holding(s) in Company
18th Aug 20217:00 amRNSHolding(s) in Company
13th Aug 20217:45 amRNSProposed Acquisition of DG Innovate & Suspension
14th Jul 20215:23 pmRNSHolding(s) in Company
14th Jul 20212:39 pmRNSHolding(s) in Company
24th Jun 20217:00 amRNSFinal Results for the Year Ended 31 December 2020
16th Jun 20217:00 amRNSHolding(s) in Company
8th Jun 202111:49 amRNSHolding(s) in Company
7th Jun 202112:04 pmRNSHolding(s) in Company
9th Apr 202110:03 amRNSHolding(s) in Company
9th Apr 20217:00 amRNSBlock Listing
1st Apr 20215:02 pmRNSHolding(s) in Company
31st Mar 20219:55 amRNSTotal Voting Rights
24th Mar 20212:06 pmRNSDirector/PDMR Share Transaction
19th Mar 20218:53 amRNSHolding(s) in Company
12th Mar 20215:36 pmRNSAdmission of previously issued shares
12th Mar 202112:50 pmRNSPublication of Prospectus
8th Mar 202111:05 amRNSSecond Price Monitoring Extn
8th Mar 202111:00 amRNSPrice Monitoring Extension
1st Mar 20214:41 pmRNSSecond Price Monitoring Extn
1st Mar 20214:36 pmRNSPrice Monitoring Extension
26th Feb 20212:06 pmRNSSecond Price Monitoring Extn
26th Feb 20212:00 pmRNSPrice Monitoring Extension
26th Feb 20217:00 amRNSEquity Fundraise Update
19th Feb 20217:00 amRNS£3.5 million Equity Fundraise
15th Feb 20212:00 pmRNSTermination of DTU Acquisition
3rd Dec 20209:44 amRNSSubscription for £55,000 of Convertible Loan Stock
5th Nov 20207:00 amRNSFurther re the Acquisition of 75% of DT Ultravert
8th Oct 20209:55 amRNSOption Surrender and Issue of Replacement Options
5th Oct 20207:00 amRNSProposed sale of Kansas Land Leases and equipment
1st Oct 202011:41 amRNSFurther re the Acquisition of DT Ultravert
30th Sep 20207:00 amRNSBoard Changes & Acquisition of Deferred Shares
10th Sep 20201:30 pmRNSInterim Results for the six months to 30 June 2020
10th Sep 20201:15 pmRNSFinal Results for the Year Ended 31 December 2019

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.